drugset
drugset / Trial / NCT01643772

OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study

NCT01643772 ↗

Phase 1 Completed 61 enrolled Mundipharma (China) Pharmaceutical Co. Ltd
RandomizedSingle-groupOpen-labelTreatment

Summary

A Single Dose PK Study of OxyNorm® immediate-release capsules 5, 10, and 20mg, and a multiple-dose PK Study of OxyNorm® immediate-release capsules 10mg in Chinese patients with pain.It will be a single center, open label, randomized, oral administration study.

Timeline

Start
2011-05
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 5 mg Oral
Subject Oxycodone Other / unclassified 10 mg Oral
Subject Oxycodone Other / unclassified 20 mg Oral

Indications

No indication recorded.